Regencell Bioscience Holdings Ltd is 4.0x more valuable than Definium Therapeutics, Inc. by market capitalization ($10.11 B vs $2.53 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | RGC | DFTX |
|---|---|---|
| Market cap | $10.11 B | $2.53 B |
| US-listed rank | #936 | #1939 |
| Net income (latest FY) | -$3.58M | -$183.79M |
| SEC filings | 82 | 445 |
Regencell Bioscience Holdings Ltd is 4.0x more valuable than Definium Therapeutics, Inc. by market capitalization ($10.11 B vs $2.53 B).
Full pages: Regencell Bioscience Holdings Ltd and Definium Therapeutics, Inc., or browse the full rankings.